Paediatric Renal Cell Carcinoma: A Rare Entity Evaluated with FDG PET-CT – Diagnostic Insights and Limitations
Article History
-
Received: ,
Accepted: ,
,
Abstract
Renal cell carcinoma (RCC) is extremely rare in the paediatric population. It accounts for only 0.3-1.3% of all paediatric tumours. Amongst renal tumours in the paediatric population, it contributes only a minuscule 2-6%, while Nephroblastoma accounts for 86-87%. These tumours also differ in terms of histology and the mutations that result in their origin based on the age of onset. Here, we present a case of renal cell carcinoma in a 6-year-old girl. She presented with left-sided abdominal pain and a mass on examination. A provisional diagnosis of neuroblastoma was made, considering the clinical presentation- paediatric age group with an abdominal mass. 18F 2-Fluorodeoxyglucose (FDG) positron emission tomography-computed tomography (PET-CT) was performed. However, the scan showed an irregular renal mass with low-grade FDG avidity and enlarged para-aortic nodes. Total nephrectomy and lymph node excision were performed, and postoperative histopathology confirmed the diagnosis of RCC with nodal metastases.
Being rare, paediatric RCC is not well documented, and results from adult studies are applied to paediatric patients in common practice. This case report emphasises the need for more clinical studies regarding the common presentations, patterns of spread and outcomes of RCC in children.
Keywords
How to cite this article: Prasad AS, Elangovan IM, Gauthaman DK, Simon S. Paediatric Renal Cell Carcinoma: A Rare Entity Evaluated with FDG PET-CT – Diagnostic Insights and Limitations. Indian J Nucl Med. 2026;41:638-42. doi: 10.25259/IJNM_189_25
INTRODUCTION
Renal cell carcinoma (RCC) is commonly seen in adults over the age of 60 years. In contrast, it is very rarely encountered in the paediatric population and accounts for less than 2% of paediatric tumours.[1] In the paediatric age group, it is seen between 9-15 years of age and is extremely rare in those younger than 9 years. In adults, RCC usually presents with the triad of haematuria, flank pain and a palpable abdominal mass. However, less than 10% of the paediatric RCC cases present with this triad. Histologically, the most frequent subtype of paediatric RCC is the translocation-associated RCC involving the Xp11.2 locus, accounting for approximately 20–40% of cases. These tumours are characterised by gene fusions involving the TFE3 gene, most commonly the ASPL-TFE3 fusion resulting from a t(X;17) (p11.2;q25) translocation and the PRCC-TFE3 fusion due to at (X;1) (p11.2;q21) translocation.[2-3] Papillary RCC follows in frequency, representing roughly 30% of paediatric RCCs and includes both type 1 and type 2 histologic variants.
The limited number of studies available on paediatric RCC makes diagnosis, management, and prognostication challenging. Despite its rarity, paediatric RCC warrants attention because of its distinct histological features, morphology and clinical presentation.[3] Understanding these differences is essential to improve diagnostic accuracy and optimise treatment strategies for this unique patient population.
CASE REPORT
We report a case of a 6-year-old girl who presented with left hypochondrial pain for 3 months and, on examination, was found to have a mass in the left abdominal region and cervical lymphadenopathy. Notably, she did not have haematuria, flank pain, vomiting, loose stools, or any other associated symptoms.
In view of abdominal mass in the paediatric age group, Neuroblastoma and Nephroblastoma were considered as possible differentials. However, the presence of cervical lymphadenopathy raised the suspicion of disseminated disease or an alternate pathology. Hence, a whole body 18F 2-Fluorodeoxyglucose (FDG) positron emission tomography-computed tomography (PET-CT) was performed. A dose of 0.1 mCi/kg of FDG was injected, and whole-body PET was acquired with low dose CT (100 mAs, 120 kV) to reduce radiation exposure, considering the patient’s age. The FDG PET-CT revealed a poorly enhancing soft tissue mass in the lower pole of the left kidney measuring 3.2 x 2.3 x 2.4 cm with low-grade FDG uptake and maximum standardised uptake value (SUVmax) of 3.2. Low-grade FDG avid multiple enlarged para-aortic nodes with central necrosis were seen; the largest node measured 3.2 x 1.5 cm, abutting the aorta with SUVmax- 2.9 [Fig 1 and 2]. A few metabolically active bilateral level II and III cervical nodes were also seen with preserved fatty hilum, the largest measuring 3.2 x 1.5 cm with SUVmax-3.7 and classified as likely reactive nodes. Overall, the PET-CT was suggestive of a primary renal malignancy with metastasis to the para-aortic abdominal lymph nodes and a probable diagnosis of nephroblastoma was given, considering the patient’s age, and a histopathology correlation was suggested. Subsequently, a CT-guided biopsy of the para-aortic node was performed, and the sample was submitted for a histopathology examination along with an immunohistochemistry panel. Gene Xpert testing and a Bacteriology workup were also done to rule out tuberculosis and other infectious causes, in view of multiple enlarged nodes, and were found to be negative, effectively ruling out infection. The immunohistochemistry panel showed positivity for CK, CK7, RCC, CD10 and TFE3, which was suggestive of metastatic renal cell carcinoma, specifically favouring MiT family translocation renal cell carcinoma (xp11 translocation renal cell carcinoma).


The patient underwent left radical nephroureterectomy along with excision of the left para-aortic mass, which measured 3x 1.5 cm. Histopathology examination showed renal cell carcinoma with papillary and clear cell architecture, and patchy psammomatous calcifications [Fig 3]. The tumour was extending into the calyces with metastatic involvement of 4/7 para-aortic nodes, resulting in a pathological staging of pT3a pN1, according to TNM classification. The patient was initiated on adjuvant therapy with Sunitinib for a period of 6 months, which she tolerated well without any significant adverse effects. Follow-up assessment was done at 6 months, 1 year, 2 years and 3 years post-treatment with abdominal ultrasonography, which revealed no evidence of residual or recurrent disease. Clinically, she has remained in good health throughout the follow-up period, with no new symptoms or complications, and is currently leading a normal life and actively attending school without any limitations in her daily activities. Written informed consent for publication was obtained from the patient’s parents.

DISCUSSION
Etiology
Renal cell carcinoma is very rare in the paediatric age group. While in adults, Renal cell carcinoma accounts for 2 % of all malignant tumours, it accounts for less than 0.1 % of malignancies in the paediatric age group.[4] A study by Uchiyama et al, showed renal cell carcinoma to account for around 1.3 % of renal malignancies in children less than 5 years of age.[4] In the paediatric age group, it tends to be more common in the adolescent population and extremely rare in the younger population.[5] The peak incidence of nephroblastoma/Wilm’s tumour is at 3 years of age, whereas renal cell carcinoma peaks at 9-15 years of age.[6] Hence, when a renal mass is found in a child, it is often not suspected as renal cell carcinoma and is evaluated for the same. In adults, renal cell carcinoma is said to show male predominance. In paediatric age groups, the results are inconsistent, with some studies showing a male predominance while others do not.[5] Therefore, no definite conclusion can be drawn regarding the same. Literature review revealed that most of the data on the prevalence of renal cell carcinoma in the paediatric age group is very limited in the Indian population. Most of the studies have been done on the Caucasian population. This emphasises the need for analysis of data from national or regional tumour registries to understand the prevalence, patterns and outcome of RCC in the Indian paediatric age group.
Clinical presentation
The classic triad of renal cell carcinoma (flank pain, haematuria and abdominal mass), while seen commonly in the adult population, is found in less than 10% of the paediatric patient population. In a study done by Selle et al, the most common presenting complaint was found to be pain in the lumbar region, followed by macroscopic haematuria and abdominal mass.[7] The patients may present with vague symptoms, such as in our case, where the presenting complaint was vague abdominal pain with no renal symptoms.
Evaluation and management
FDG PET-CT is not recommended as a primary imaging modality in the routine evaluation of paediatric renal tumours. However, in the current case, the presence of atypical cervical lymphadenopathy raised suspicion for disseminated disease or alternate pathology, and hence, FDG PET-CT was done. It helped in assessing disease burden as well as categorising the cervical lymphadenopathy as reactive nodes. Although paediatric renal cell carcinoma is rare and often not included in the differential diagnosis, it should be kept in mind while interpreting imaging findings due to its varied management. Lymph nodal metastases have been documented even in small RCC lesions in the paediatric age group.[8] According to the United Kingdom Children’s Cancer study group, in children who underwent renal biopsies, severe complications such as a drop in haemoglobin, tumour rupture and massive bleed requiring emergency nephrectomy were noted.[9] Therefore, renal biopsy must be done with the utmost caution and avoided whenever possible. In this case, the suspicious nodes were detected on imaging, which helped in avoiding renal biopsy, effectively decreasing patient morbidity and mortality. Radical nephrectomy with nodal clearance is found to be the best treatment with good survival, as the tumour is found to be radio and chemo-resistant intrinsically.[8]
CONCLUSION
Renal cell carcinoma, though exceedingly rare in the paediatric population, has a poor prognosis in comparison to Wilm’s tumour. Early diagnosis and complete surgical resection with nodal clearance are critical to achieve favourable outcomes. This is evident in the present case, where the patient remains healthy and leads a normal life nearly three years after surgery. Evidence suggests that the stage at diagnosis and the completeness of resection are the most significant prognostic factors. FDG PET-CT shows lower uptake, and its use needs justification vis-à-vis CECT. Studies similar to those in adult RCCs are needed to determine which specific pathologies may benefit from PETCT. However, this case study shows that in paediatric patients presenting with renal masses, RCC is a rare possibility. In conclusion, FDG PET-CT may complement conventional imaging in selected cases by identifying nodal or distant metastases.
Author contributions:
ASP: Concept, literature search, clinical studies, data collection and analysis, manuscript preparation, manuscript editing; IME: Definition of intellectual content, manuscript editing, manuscript review; DKG: Concept, data collection and analysis, manuscript editing, manuscript review, literature search; SS: Concept, design, manuscript review, supervision
Ethical approval:
Institutional Review Board approval is not required.
Declaration of patient consent:
The authors certify that they have obtained all appropriate patient consent forms. In the form, the patient has given consent for their images and other clinical information to be reported in the journal. The patient understand that the patient’s names and initials will not be published and due efforts will be made to conceal their identity, but anonymity cannot be guaranteed.
Conflicts of interest:
There are no conflicts of interest.
Use of artificial intelligence (AI)-assisted technology for manuscript preparation:
The authors confirm that there was no use of artificial intelligence (AI)-assisted technology for assisting in the writing or editing of the manuscript and no images were manipulated using AI.
Financial support and sponsorship: Nil.
References
- Paediatric renal cell carcinoma. Surg Pathol Clin. 2010;3:641-51.
- [CrossRef] [PubMed] [Google Scholar]
- Renal cell carcinoma in children and young adults: Clinicopathological, immunohistochemical, and VHL gene analysis of 46 cases with follow-up. Int J Surg Pathol. 2011;19:170-9.
- [CrossRef] [PubMed] [Google Scholar]
- Morphologic and molecular characterization of renal cell carcinoma in children and young adults. Am J Surg Pathol. 2004;28:1117-32.
- [CrossRef] [PubMed] [Google Scholar]
- Treatment of childhood renal cell carcinoma with lymph node metastasis: two cases and a review of literature. Journal of surgical oncology. 2000;75:266-9.
- [CrossRef] [PubMed] [Google Scholar]
- Characteristics and outcome of children with renal cell carcinoma: A narrative review. Cancers (Basel). 2020;12:1776.
- [CrossRef] [PubMed] [Google Scholar]
- Imaging characteristics of paediatric renal cell carcinoma and Wilms tumor and its impact on their management and outcomes--A case report and review of literature. J Kidney Cancer VHL. 2025;12:30.
- [CrossRef] [PubMed] [Google Scholar]
- Population-based study of renal cell carcinoma in children in Germany 1980-2005: More frequently localized tumors and underlying disorders compared with adult counterparts. Cancer. 2006;107:2906-14.
- [CrossRef] [PubMed] [Google Scholar]
- The role of biopsy in the diagnosis of renal tumors of childhood: Results of the UKCCSG Wilms tumor study 3. Med Pediatr Oncol. 2003;40:18-22.
- [CrossRef] [PubMed] [Google Scholar]
- Renal cell carcinoma in the pediatric population: A case report and review of the literature. Urol Case Rep. 2023;49:102453.
- [CrossRef] [PubMed] [Google Scholar]

